Mark N. Lazarus

Learn More
OBJECTIVES To correlate the kinetics of B-cell repopulation with relapse after B-cell depletion therapy in SLE patients and address whether variation in relapse rate, B-cell numbers and phenotype are related to anti-dsDNA antibody levels. METHODS Sixty-one patients with refractory SLE were treated with a standard rituximab regimen. Clinical and(More)
  • 1